Study sexual side effects in schizophrenia with diabetes
Part of Hormones & metabolism, Mental health clinical trials.
This study looks at how sexual functioning is affected in people with schizophrenia, especially in those who also have diabetes or weight-related risk. It also examines how psychiatric medicines and diabetes/weight factors may be connected, which could help improve care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a schizophrenia-spectrum diagnosis
- You have diabetes, or past/present prediabetes on blood tests, or a BMI of 30 or higher
- You are currently taking at least one antipsychotic medicine (for example, pills or injections)
- You can complete a sex-function questionnaire called CSFQ-14
- You can speak and understand Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special clinic that helps people with schizophrenia or bipolar disorder manage their weight and metabolic health while taking antipsychotic medication. It focuses on improving overall health with practical support.
This trial tests whether bromocriptine can help people who have schizophrenia and prediabetes (higher-than-normal blood sugar but not diabetes). You may be able to join if your blood sugar and other health factors fit the study rules.
This study tests whether unusual insulin action in the brain is linked to thinking problems and body/metabolic issues in schizophrenia. It may help researchers understand the cause and identify targets for future treatments.
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.
This study looks at how immune system health relates to brain changes in people with schizophrenia. It uses brain imaging and electrical activity tests to understand these connections.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.